Supplementary Files
Keywords
How to Cite
Abstract
Introduction:
Daily oral iron and folic acid intake is recommended as part of antenatal care but adherence to this regimen, due to gastrointestinal side effects, interrupted intake of iron. Weekly oral iron therapy has been introduced as an alternative to the daily iron regimen.
Objective:
To compare mean hemoglobin and hematocrit in non-anemic pregnant females receiving daily oral iron versus weekly iron supplements in third trimester of pregnancy.
Material and Methods
This randomized Controlled Trial study was carried out in department of obstetrics and gynecology of holy family hospital, Rawalpindi during 20th November 2019 to 20th May 2020. 70 pregnant females of 15 to 45 years, with singleton pregnancies, at gestational amenorrhea 14 to 22 weeks at the time of inclusion with hemoglobin level 11g/dl and above were included. They were randomly divided into two equal groups using SPSS, Group A (35) received daily oral iron and Group B, 35 received weekly oral iron.
Results:
There was no statistically significant difference could be detected between both groups as regards the hemoglobin level before starting iron supplementation and duration of supplementation and this can be attributed to proper randomization. Mean post treatment hemoglobin was 13.2±0.93 g/dl in group A and 12.9±0.95 g/dl in group B (0.118), mean change of hemoglobin was 1.07±0.34 g/dl in group A and 0.63±0.56 g/dl in group B (0.000), mean post treatment hematocrit was 35.857±0.87 % in group A and 32.857±0.91 % in group B (p 0.000), mean change of hematocrit was 2.942±0.59 % in group A and 1.000±0.00 % in group B (p 0.000).
Conclusion:
Weekly iron supplementation as a prophylaxis in non-anemic pregnant women is as good as daily supplementation as regards the hemoglobin level.
References
World Health Organization (WHO), (2015): Hemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System . Cochrane Database Syst Rev., 10.1002/14651858.CD009997.pub2.
Boschi-Pinto C, Young M, Black RE. The Child Health Epidemiology Reference Group reviews of the effectiveness of interventions to reduce maternal, neonatal and child mortality. Int J Epidemiol. 2010;39 Suppl 1(Suppl 1):i3‐i6.
Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, Peña-Rosas JP, Bhutta ZA, Ezzati M, Nutrition Impact Model Study Group. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. The Lancet Global Health. 2013 Jul 1;1(1):e16-25.
Benoist BD, McLean E, Egll I, Cogswell M. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia 2008.
World Health Organization. Guideline: daily iron and folic acid supplementation in pregnant women. World Health Organization; 2012.
Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues?.Blood Cells Mol Dis.2003;30(3):288‐297.
Guideline: Intermittent Iron and Folic Acid Supplementation in NonAnaemic Pregnant Women. Geneva: World Health Organization; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK299510/.
Goonewardene IMR, Senadheera DI. Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy. J Obstet Gynaecol Res. 2018;44(3):417‐424.
Sipra B, Shanti S, Kimmi A. Effect of weekly iron supplementation on iron indices in pregnant women. Int J Med Res Health Sci. 2015;4(4):857-860.
Sadighian F, HaydehSamiei H, Alaoddolehei H, Kalantari N. Efficacy of daily versus intermittent administration of iron supplementation in anemia or blood indices during pregnancy. Caspian J Intern Med. 2013;4(1):569‐573.
World Health Organization(WHO), (2011): The global prevalence of anemia in 2011. Geneva: World Health Organization. Cochrane Database Syst Rev.,110.1002/14651858.CD009997.pub2.
Mumtaz Z, Shahab S, Butt N, Rab MA, DeMuynck A. Daily iron supplementation is more effective than twice weekly iron supplementation in pregnant women in Pakistan in a randomized double-blind clinical trial. The Journal of nutrition. 2000 Nov 1;130(11):2697- 702.
Khangura RK, Torti S, Tesfay L, Hammer E, Bakaysa S, Campbell W. Daily vs. Intermittent iron Therapy in Moderate Iron Deficient Pregnant Patients: A Randomized non-Inferiority Trial. AJOG. February 2021; 224(2), Supplement, S28. DOI: https://doi.org/10/1016/j.ajog.2020.12.114
Chu Lam MT, Khandakar B, Heon I, Overbey J, Brustman L, Rosenn B. Daily vs. Alternate Day Iron for Pregnant Women with Iron Deficiency Anemia: Randomized Controlled Trial. AJOG. February 2021; 2024(2), Supplement, S107. DOI: https://doi.org/10/1016/j.ajog.2020.12.179
Yaznil MR, Lubis MP, Lumbanraja SN, Barus MNG, Sarirah M. Comparison of maternal outcomes of daily and weekly iron tablet supplementation in pregnant women in Coastal Region, Medan, Indonesia. Open Access Maced J Med Sci. September 2020; 8(B):1088-91 DOI.org/10.3889/oamjms.2020.5056
Abdelgawad M, Mansour D, Mohammed M. Daily versus weekly oral iron supplementation in pregnant women: A randomized controlled clinical trial. Evidence Based Women's Health Journal 2021;2(2):120-126. DOI:10.21608/ebwhj.2019.17526.1031
Demuth IR, Martin A, Weissenborn A. Iron supplementation during pregnancy - a cross-sectional study undertaken in four Germanstates. BMC Pregnancy Childbirth. 2018;18(1):491.
Bouzari Z, Basirat Z, Zeinal Zadeh M, Cherati SY, Ardebil MD, Mohammadnetaj M, Barat S. Daily versus intermittent iron supplementation in pregnant women. BMC Res Notes. 2011 Oct 25;4:444.
Kumar S, Dubey N, Khare R. Study of serum transferrin and serum ferritin during pregnancy and their correlation with pregnancy outcome. Int J Med Sci Public Health. 2017;6:118-22 DOI.org/10.5455/ijmsph.2017.04072016570
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 Saira Asif